Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Despite Brexit planning, EMA fears disruption for 39 medicinesDespite Brexit planning, EMA fears disruption for 39 medicines
    Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperationPharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation
    Asia Healthcare in talks to acquire Nova IVI FertilityAsia Healthcare in talks to acquire Nova IVI Fertility
    Veneeth Purushotaman joined to Aster DM Healthcare as the Group CIOVeneeth Purushotaman joined to Aster DM Healthcare as the Group CIO
    FIRST: Needle, syringe makers tell government to regulate their pricesFIRST: Needle, syringe makers tell government to regulate their prices
    Boston Scientific introduces LithoVue Empower-kidney stone reterival deviceBoston Scientific introduces LithoVue Empower-kidney stone reterival device
    Boosting profitability: Novartis to cut 2,200 jobs in SwitzerlandBoosting profitability: Novartis to cut 2,200 jobs in Switzerland
    Gilead to launch low-cost generic versions of its hepatitis drugsGilead to launch low-cost generic versions of its hepatitis drugs
    USFDA completes inspection of Biocon drug substance unit at BengaluruUSFDA completes inspection of Biocon drug substance unit at Bengaluru
    Cipla received USFDA approval for AlbendazoleCipla received USFDA approval for Albendazole
    With new blood test, Roche dives deeper into personal cancer careWith new blood test, Roche dives deeper into personal cancer care
    Bayer Subside Monsanto India appoints Cherukuri Ravishankar as new MDBayer Subside Monsanto India appoints Cherukuri Ravishankar as new MD
    PrevNext

    Popular Stories

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Cyient gets nod to manufacture assemblies for COVID-19 diagnosis units, X-ray system

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok